Nuvalent (NUVL)
(Real Time Quote from BATS)
$85.07 USD
+0.11 (0.13%)
Updated Sep 6, 2024 03:45 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Nuvalent, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | NA |
Cost Of Goods | 0 | 0 | 0 | 0 | NA |
Gross Profit | 0 | 0 | 0 | 0 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 149 | 86 | 46 | 17 | 0 |
Income After Depreciation & Amortization | -149 | -86 | -46 | -17 | 0 |
Non-Operating Income | 23 | 4 | -1 | 2 | NA |
Interest Expense | 0 | 0 | 0 | 0 | NA |
Pretax Income | -126 | -82 | -46 | -15 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -126 | -82 | -46 | -15 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -126 | -82 | -46 | -15 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -160 | -86 | -46 | -17 | 0 |
Depreciation & Amortization (Cash Flow) | -10 | 0 | 0 | 0 | NA |
Income After Depreciation & Amortization | -149 | -86 | -46 | -17 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 58.22 | 49.67 | 21.78 | NA | NA |
Diluted EPS Before Non-Recurring Items | -2.17 | -1.65 | -2.13 | NA | NA |
Diluted Net EPS (GAAP) | -2.17 | -1.65 | -2.13 | NA | NA |
Fiscal Year end for Nuvalent, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 65.15 | 52.58 | 46.44 | 38.78 | 34.06 |
Income After SG&A, R&D, and Dept/Amort Expenses | -65.15 | -52.58 | -46.44 | -38.78 | -34.06 |
Non-Operating Income | 8.15 | 8.49 | 8.15 | 5.14 | 4.97 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -57.00 | -44.10 | -38.29 | -33.65 | -29.09 |
Income Taxes | 0.17 | 0.38 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -57.17 | -44.48 | -38.29 | -33.65 | -29.09 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -57.17 | -44.48 | -38.29 | -33.65 | -29.09 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 64.61 | 64.15 | 62.18 | 57.09 | 56.87 |
Diluted EPS Before Non-Recurring Items | -0.88 | -0.69 | -0.62 | -0.59 | -0.51 |
Diluted Net EPS (GAAP) | -0.88 | -0.69 | -0.63 | -0.59 | -0.51 |